T'Way Air Co., Ltd. (KRX:091810)

CTI BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	408,615	516,417	479,353	396,309	352,400	275,233
Market Cap Growth	-22.67%	7.73%	20.95%	12.46%	28.04%	4.02%
Enterprise Value	692,577	635,820	551,581	744,326	614,676	577,117
Last Close Price	1899.00	2400.00	2390.00	2475.00	2980.16	2328.25
PE Ratio	-	-	4.85	-	-	-
Forward PE	-	6.44	7.29	23.39	-	-
PS Ratio	0.26	0.34	0.36	0.75	1.64	1.02
PB Ratio	12.06	6.28	3.05	6.67	7.44	2.35
P/TBV Ratio	13.46	6.54	3.21	9.54	11.98	2.41
P/FCF Ratio	4.76	2.98	1.27	2.56	11.14	-
P/OCF Ratio	2.16	1.90	1.15	2.39	10.04	-
EV/Sales Ratio	0.44	0.41	0.41	1.42	2.87	2.14
EV/EBITDA Ratio	152.04	6.10	2.30	-	-	-
EV/EBIT Ratio	-	-	3.96	-	-	-
EV/FCF Ratio	8.07	3.67	1.46	4.80	19.43	-
Debt / Equity Ratio	15.11	6.32	2.38	6.88	6.81	2.92
Debt / EBITDA Ratio	112.41	4.99	1.56	-	-	-
Debt / FCF Ratio	5.97	3.00	0.99	2.64	10.19	-
Asset Turnover	1.08	1.08	1.16	0.59	0.30	0.36
Inventory Turnover	44.31	44.69	60.52	48.11	31.45	35.63
Quick Ratio	0.51	0.56	0.85	0.51	0.34	0.56
Current Ratio	0.67	0.75	0.98	0.59	0.42	0.67
Return on Equity (ROE)	-134.81%	-55.03%	91.56%	-222.35%	-190.16%	-90.15%
Return on Assets (ROA)	-5.37%	-0.54%	7.49%	-7.31%	-12.87%	-14.40%
Return on Capital (ROIC)	-13.58%	-1.35%	17.44%	-15.50%	-22.39%	-21.62%
Return on Capital Employed (ROCE)	-	-	17.00%	-	-	-
Earnings Yield	-38.82%	-12.76%	20.68%	-29.94%	-44.34%	-50.09%
FCF Yield	21.01%	33.56%	78.72%	39.13%	8.98%	-31.16%
Buyback Yield / Dilution	1.10%	1.02%	-49.16%	-30.97%	-74.19%	-12.38%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.